IL26 and neoplasm: In Epstein–Barr virus (EBV)-infected nasopharyngeal epithelial cells, the responses to interleukin (IL)-26-induced signal transducer and activator of transcription 3 (STAT3) activation were enhanced to promote tumor progression.